DSFCL Q1FY27 Unaudited Results: Total Income ₹916 Crore, Net Profit ₹242 Crore
DCM Shriram Fine Chemicals Limited reported unaudited results for Q1FY27. Total income was ₹91.60 crore (standalone) and ₹91.84 crore (consolidated). Net profit after tax was ₹2.42 crore (standalone) and ₹2.59 crore (consolidated). Basic EPS stood at ₹0.28 (standalone) and ₹0.30 (consolidated).
The announcement provides unaudited quarterly financial results, which are a routine disclosure. The financial performance shows a decline in profits compared to the previous year, which could influence investor sentiment. However, there are no significant new corporate actions or strategic shifts announced.
The financial results show a slight decrease in total income compared to the previous year's quarter, and a significant drop in net profit. While the company is profitable, the year-on-year decline in key financial metrics leads to a neutral sentiment.
DCM Shriram Fine Chemicals Limited (DSFCL) has published its unaudited financial results for the quarter ended June 30, 2026. The total income from operations for the quarter stood at ₹9,159.96 lakh (₹91.60 crore) on a standalone basis and ₹9,184.13 lakh (₹91.84 crore) on a consolidated basis.
The company reported a net profit after tax of ₹241.64 lakh (₹2.42 crore) on a standalone basis and ₹259.37 lakh (₹2.59 crore) on a consolidated basis for the quarter. Basic and diluted earnings per share were ₹0.28 (standalone) and ₹0.30 (consolidated).
The results, reviewed by the Audit Committee and approved by the Board of Directors on August 14, 2026, have undergone a limited review by the statutory auditor. The financial results are prepared in accordance with Indian Accounting Standards. The company's business activities fall within a single primary business segment: manufacturing of organics and fine chemicals in India. The Board also noted that the recent consolidation of Labour Codes by the Government of India is not expected to have a material financial impact on the company.
What to do with a filing like this
DCM Shriram Fine Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by DCM Shriram Fine Chemicals Limited. Read the original for the full detail.